Table 1.
Clinical and laboratory characteristics of control subjects and patients with T2D before (T2D Pre) and after (T2D Post) exercise training.
| Control | T2D Pre | T2D Post | |
|---|---|---|---|
| Sex (M/F) | 4M/2F | 4M/2F | ------- |
| Age (yr) | 48 ± 2 | 54 ± 4 | ------- |
| Body mass (kg) | 80 ± 6 | 88 ± 11 | 85 ± 11 |
| BMI (kg.m−2) | 28 ± 2 | 29 ± 2 | 29 ± 2 |
| Waist Girth (cm) | 98 ± 5 | 105 ± 7 | 102 ± 7b |
| Wmax (W) | 202 ± 25 | 173 ± 25 | 194 ± 28b |
| HRmax (bpm) | 170 ± 6 | 165 ± 3 | 170 ± 4b |
| Fasting glucose (mmol.l−1) | 5.8 ± 0.4 | 9.8 ± 1.2a | 8.9 ± 0.9b |
| 2 h plasma glucose (mmol.l−1) | 6.2 ± 0.2 | 17.9 ± 2.4 | 15.6 ± 2.4 |
| Fasting insulin (pmol.l−1) | 59 ± 13 | 79 ± 24 | 70 ± 12 |
| Matsuda Index | 5.74 ± 1.30 | 3.24 ± 0.36 | 3.78 ± 0.68 |
| Triglycerides (mmol.l−1) | 1.35 ± 0.3 | 2.47 ± 0.62 | 2.29 ± 0.56 |
| Total cholesterol (mmol.l−1) | 5.87 ± 0.52 | 5.93 ± 0.29 | 5.20 ± 0.21 |
| HDL cholesterol (mmol.l−1) | 1.16 ± 0.03 | 1.10 ± 0.1 | 1.07 ± 0.1 |
Data are given as means ± SE (n=6).
a
p<0.05 vs. control;
b
p<0.05 vs. type 2 diabetes pre. HRmax, maximum heart rate during incremental exercise test to exhaustion; Wmax, peak power.